David Avigan
Clinical trials sponsored by David Avigan, explained in plain language.
-
New immune therapy combo shows promise in early AML trial
Disease control Recruiting nowThis study tests a new treatment for acute myeloid leukemia (AML) that uses a patient's own immune cells, trained to attack the cancer, combined with standard chemotherapy drugs. About 30 adults with AML will receive this therapy to see if it is safe and works. The goal is to imp…
Phase: PHASE1 • Sponsor: David Avigan • Aim: Disease control
Last updated May 17, 2026 00:48 UTC
-
New vaccine boosts CAR-T power against tough blood cancer
Disease control Recruiting nowThis early-phase study tests whether adding a personalized cancer vaccine (DC/MM fusion) to standard CAR-T cell therapy is safe and works better for people with multiple myeloma that has come back or not responded to treatment. About 25 adults will receive the vaccine along with …
Phase: PHASE1 • Sponsor: David Avigan • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Custom-Made vaccine trial offers new hope for Tough-to-Treat blood cancer
Disease control Recruiting nowThis early-stage study is testing whether a personalized cancer vaccine made from a patient's own cells, when combined with an immunotherapy drug called elranatamab, is safe and effective for treating multiple myeloma that has returned or stopped responding to standard treatments…
Phase: PHASE1 • Sponsor: David Avigan • Aim: Disease control
Last updated Apr 22, 2026 15:59 UTC